Special Project in Non-Metastatic Castrate Resistant Prostate Cancer

Prostate Cancer Canada (PCC) has offered investigator-initiated Special Project in Non-Metastatic Castrate Resistant Prostate Cancer (NM-CRPC). This request for applications (RFA) solicited proposals from groups interested in combining various real world data sources (i.e. detailed chart review at prostate cancer centres with health administrative databases) to obtain high quality epidemiological data, outcomes and costs among the population of prostate cancer patients in at least two provinces in Canada that together represent greater than 50% of the population.
 
The key objectives were:
  • to obtain prevalence, incidence and survival probability estimates of prostate cancer, stratified by age and year of diagnosis from provincial cancer registries;
  • to identify pathways leading to and factors associated with the target condition (NM-CRPC);
  • to estimate annual incidence and prevalence of NM-CRPC, stratified probability of developing NM-CRPC and transition probabilities that characterize the prognosis from NM-CRPC to metastasis and end-of-life;
  • to estimate health care resource use and costs for health states in the recurrent disease model.
 
Award amount: up to $450,000 over 2 years

 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Canadians Encouraged to Wear Plaid for Dad before Father's Day

TORONTO, ON -- (May 17, 2017) -- Wednesday morning will mark the launch of Canada's third annual Plaid for Dad campaign in support of prostate cancer research.
More

The Alternatives

Many men are still uncomfortable with getting their prostates checked, but what are the alternatives?
More

Prostate Cancer Canada encouraged by growing political support for PSA test coverage in BC

Vancouver BC - April 11, 2017 - Prostate Cancer Canada (PCC) applauds the first provincial party in BC to announce their commitment to cover the cost of PSA (prostate-specific antigen) tests for men when ordered by a physician.
More


Click here for news archive